CEL — Celadon Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- £73.84m
- £76.90m
- £0.02m
Annual cashflow statement for Celadon Pharmaceuticals, fiscal year end - December 31st, millions except per share.
2018 August 31st | 2019 August 31st | 2020 August 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 16 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final | Final |
| Net Income/Starting Line | — | -0.206 | -0.187 | -0.722 | -17.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | — | — | — | — | 11.5 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | — | 0.032 | 0.027 | -1.99 | -0.648 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | — | -0.174 | -0.16 | -2.71 | -6.1 |
| Capital Expenditures | — | — | — | — | -2.09 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 3.48 |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | — | — | 1.39 |
| Financing Cash Flow Items | — | -0.308 | 0 | — | -0.024 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 5.82 | 0 | 1.68 | 5.95 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | — | 5.65 | -0.16 | -1.03 | 1.24 |